PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial | Nature Medicine
CAR T-Cell Therapy: Procedure, Prognosis & Side Effects
Cancers | Free Full-Text | Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment | HTML
CAR T Cell Therapy for The Treatment of Cancer - CancerConnect
PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model: Molecular Therapy - Oncolytics
CAR-T Cells: A Systematic Review and Mixed Methods Analysis of the Clinical Trial Landscape: Molecular Therapy
Cancers | Free Full-Text | Chimeric Antigen Receptor T-Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer
Remodeled CAR T-Cell Therapy Causes Fewer Side Effects - NCI
City of Hope Opens State-of-Art CAR T Cell Phase I Clinical Trial for Prostate Cancer
Frontiers | The Potential of CAR T Cell Therapy in Pancreatic Cancer | Immunology
Frontiers | Making CAR T Cells a Solid Option for Solid Tumors | Immunology
The expansion of targetable biomarkers for CAR T cell therapy | Journal of Experimental & Clinical Cancer Research | Full Text
CAR-T cell therapy: a potential new strategy against prostate cancer | Journal for ImmunoTherapy of Cancer | Full Text
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial | Nature Medicine
Frontiers | CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape | Immunology
CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI
Current Progress in CAR-T Cell Therapy for Solid Tumors
Frontiers | Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous Venture | Immunology
Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer - European Urology
CAR T Cell Therapy | Penn Medicine
Clinical CAR-T Cell and Oncolytic Virotherapy for Cancer Treatment: Molecular Therapy
The potential of CAR T cell therapy for prostate cancer | Nature Reviews Urology
Promising CAR T-PSMA Clinical Trial in Patients with Metastatic Castration Resistant Prostate Cancer | Moffitt
Gene modification strategies for next-generation CAR T cells against solid cancers | Journal of Hematology & Oncology | Full Text
PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models | PLOS ONE
FDA lifts clinical hold on trial of CAR-T for metastatic pancreatic, prostate cancers
Moffitt
